Literature DB >> 34754592

Extraosseous extradural ewing sarcoma of the thoracic spine: Case report and literature review.

Minaam Farooq1, Biah Mustafa1, Kashif Ali Sultan2,3, Mohammad Ashraf4, Naveed Ashraf2, Abubakar Siddique3,5.   

Abstract

BACKGROUND: As part of the 'small round-cell tumor' family, Ewing's sarcoma (ES) is a malignant mesenchymal tumor classified as a primitive neuroectodermal tumor (PNET). Within the PNETs, spinal extraosseous extradural lesions are exceedingly rare. CASE DESCRIPTION: A 19-year-old male presented with a one-month history of back pain and paraparesis with loss of urinary control. The MRI revealed an intradural, extramedullary mass at the T3-T4 level. Intraoperatively, the tumor was solely extradural, without evidence of local invasion; it was entirely removed. Due to the high risk of metastasis, the patient was subsequently treated with chemotherapy and radiation. In addition, similar studies on PNETs were reviewed.
CONCLUSION: A 19-year-old male presented with a paraparesis attributed to an extraosseous extradural ES at the T3-T4 level. Following total gross resection, he was successfully managed with chemotherapy and radiation. The patient has been in remission for one month. Copyright:
© 2021 Surgical Neurology International.

Entities:  

Keywords:  Ewing’s sarcoma; Extradural; Extraskeletal; Primitive neuroectodermal tumor; Spine

Year:  2021        PMID: 34754592      PMCID: PMC8571188          DOI: 10.25259/SNI_790_2021

Source DB:  PubMed          Journal:  Surg Neurol Int        ISSN: 2152-7806


INTRODUCTION

Primary spinal extradural Ewing’s sarcoma (ES), also known as primitive neuroectodermal tumors (PNETs), are rare. According to the World Health Organization classification, PNET is an undifferentiated round cell tumor that arises from primitive neuroepithelial cells. They constitute a heterogeneous group of malignant tumors of childhood and early adulthood. Spinal Epidural PNET/peripheral PNET have an incidence of <1% of primary spinal tumors.[4] Here, we evaluated a 19-year-old male with an extradural extraosseous T3-T4 ES managed with total gross excision, radiation, and chemotherapy, showing no evidence of recurrence a month later.

CASE PRESENTATION

Clinical presentation

A 19-year-old male presented with a progressive T5-level paraparesis, a T5 sensory level, and sphincter dysfunction of one month’s duration [Table 1].
Table 1:

Summary of current case.

Summary of current case.

Radiological evaluation

The thoracic MRI showed an intradural extramedullary lesion at the T3-T4 level; it was well-defined, predominantly right-sided with significant cord compression and lobulated, measuring 3.6 cm × 1.7 cm × 1.5 cm with “tentacles” extending superiorly. On MRI, it was isointense on T1, and heterogeneously hyperintense on T2 weighted sequences, showing partial peripheral enhancement with GadoliniumDTPA. There was also obliteration of CSF tab the level of T3/ T4 maximal compression [Figures 1 and 2].
Figure 1:

Preoperative sagittal view of current case showing (a) T1 (without contast), (b) T1 (with contrast), (c) T2 (without contrast)

Figure 2:

Preopertaive axial view of current case showing (a) T1 (without contrast), (b) T1 (with contrast), (c) T2 (without contrast).

Preoperative sagittal view of current case showing (a) T1 (without contast), (b) T1 (with contrast), (c) T2 (without contrast) Preopertaive axial view of current case showing (a) T1 (without contrast), (b) T1 (with contrast), (c) T2 (without contrast).

Surgery

The patient underwent a T3-T4 laminectomy. The lesion proved to be entirely extradural in location and was soft and vascular; the lesion was fully excised. However, there was profuse intraoperative bleeding, requiring 1 unit of RBC transfusion.

Pathology and molecular cytogenetics confirmation of the diagnosis of epidural EWS

The histological examination revealed a malignant neoplasm consistent with Epidural EWS; cells were arranged in groups, sheets, and nests. Individual tumor cells were round/ oval, had uniform round nuclei and clear cytoplasm; a few cells showed a high nucleus to cytoplasm (N/C) ratio and prominent nucleoli. Atypical mitotic figures and areas of necrosis were also seen. [Figure 3].
Figure 3:

Immunohistochemically, the cells were positive for CD99. The complete reactivity pattern of the specimen is shown in Table 2.

Immunohistochemically, the cells were positive for CD99. The complete reactivity pattern of the specimen is shown in Table 2.
Table 2:

Summary of literature review.

Molecular cytogenetics further confirmed the diagnosis, along with a fluorescence in situ hybridization analysis to assess the EWS gene locus.

Adjuvant therapy

Following confirmation, the patient was treated with a multi-agent chemotherapy regimen as well as radiation therapy.

Review of literature

Forty-three studies have previously reported a total of 59 cases. The findings of these studies, including our current case, are summarised in [Table 2]. Summary of literature review.

DISCUSSION

Till today, about 40 case reports/series of extradural spinal ED have been reported, mostly occurring in adolescents and young adults and mostly in males. The most common presenting complaint is chronic back pain, paraparesis, and sphincter dysfunction later in the clinical course. Most extradural ES involve multiple levels and may vary in location for each case, mostly presenting in the sacral region. CT scans best document dumb-bell-shaped tumors with foraminal widening,[1] and scalloping of bones,[6] soft tissue mass with or without pleural and rib damage.[5] Periodic acid-Schiff stain was positive in all reported cases. On light microscopy, poorly differentiated, small round cells are seen with mitotic figures, a high N/C ratio, and scanty cytoplasm that form nests, sheets, lobules, or occasionally rosettes. On electron microscopy, scanty cytoplasmic organelles are seen, accompanied by growth cones suggestive of glial cell differentiation.[5] About 95% of the EES cases show non-specific CD99 (MIC2) positivity.[3] Other tumor markers that are usually ordered include CD-34, CD-20, CD-10, Tdt, and others. The t(11;22) (q24;q12) translocation is a chromosomal abnormality seen in 90% of cases of ES, which results in the formation of a fusion transcript.[2] Treatment regimens include partial/gross total resection, followed by radiotherapy and chemotherapy. Cases not receiving any adjuvant therapy typically died only a few months later.

CONCLUSION

Extraskeletal Ewing sarcomas are exceedingly rare. The best outcomes are achieved with gross total resection, followed by adjuvant radiation and chemotherapy.
  6 in total

1.  Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours.

Authors:  O Delattre; J Zucman; B Plougastel; C Desmaze; T Melot; M Peter; H Kovar; I Joubert; P de Jong; G Rouleau
Journal:  Nature       Date:  1992-09-10       Impact factor: 49.962

2.  Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases.

Authors:  Andrew L Folpe; John R Goldblum; Brian P Rubin; Bahig M Shehata; Wendy Liu; Angelo P Dei Tos; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2005-08       Impact factor: 6.394

3.  MR of primary extraosseous Ewing sarcoma.

Authors:  K Allam; G Sze
Journal:  AJNR Am J Neuroradiol       Date:  1994-02       Impact factor: 3.825

4.  Spinal epidural extraskeletal Ewing sarcoma: MR findings in two cases.

Authors:  J H Shin; H K Lee; S C Rhim; K J Cho; C G Choi; D C Suh
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

Review 5.  [Epidural extraskeletal Ewing sarcoma. Case report and literature review].

Authors:  Rafael García-Moreno; Luis Miguel Bernal-García; Manuel Pineda-Palomo; Marcos Botana-Fernández; Ignacio Javier Gilete-Tejero; José Manuel Cabezudo-Artero
Journal:  Neurocirugia (Astur)       Date:  2014-12-10       Impact factor: 0.553

6.  Primary Spinal Extradural Extraosseous Primitive Neuroectodermal Tumor/Ewing's Sarcoma: A Critical Analysis and Review.

Authors:  Akshay Shrirang Patil; Prasheelkumar Premnarayan Gupta; Sandeep Wasudeorao Iratwar
Journal:  Asian J Neurosurg       Date:  2021-05-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.